C12Q 2539/103
Serial analysis of gene expression [sage]
Official title: Serial analysis of gene expression [SAGE]
C12Q2539/103 (Serial analysis of gene expression [sage]) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Q- Granted patents
- 3
- Published applications
- 5
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 31 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Methods and compositions related to prostate cancer therapeutics31 May 2022US 11,345,956 B2The Johns Hopkins University
- Single cell RNA and mutational analysis PCR (SCRM-PCR): a method for simultaneous analysis of DNA and RNA at the single-cell level30 Nov 2021US 11,186,865 B2Agency for Science, Technology and Research
- P53-induced apoptosis13 Aug 2002US 6,432,640 B1The Johns Hopkins University
- Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment management7 Dec 2023US 2023/0395263 A1GeneCentric Therapeutics, Inc.
- Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment management11 Mar 2021US 2021/0074431 A1
- Single cell rna and mutational analysis pcr (scrm-pcr): a method for simultaneous analysis of dna and rna at the single-cell level25 Apr 2019US 2019/0119721 A1Agency for Science, Technology and Research
- Methods and compositions related to prostate cancer therapeutics28 Sep 2017US 2017/0275673 A1The Johns Hopkins University
- P53-induced apoptosis9 May 2002US 2002/0055097 A1The Johns Hopkins University
Most cited
By later US patents